CD19 Rituximab

Description: 
This protocol provides the client with a CD19 and CD20 B panel for the monitoring of rituximab treatment.
Clinical details: 
Rituximab is a chimeric anti-human monoclonal antibody that reacts with the CD20 antigen and is used to treat B cell lymphoma in the adult. It is also used to treat moderate-to-severe forms of Rheumatoid arthritis and other diseases involving the immune system.
Synonyms or keywords: 
CD19 Rituximab protocol, CLL, Rheumatoid arthritis, Immunophenotyping Rituximab monitoring.
Location: 
Sample type and Volume required: 
EDTA Whole Blood 1ml
Turnaround time: 
48 hours
Special sample instructions: 

Do not refrigerate samples

Storage and transport: 
Store and transport samples at room temperature. Maximum sample age for analysis is 48hrs.
Contacts:
Flow Cytometry/Immunophenotyping Laboratory at Guy's and St Thomas' Clinical Advisory Service
Guy's Hospital
Monday - Friday 9:00 - 17:00
4th Floor – Southwark Wing
Great Maze Pond
London SE1 9RT
Telephone – 020 7188 2709

St Thomas’ Hospital
Monday – Friday 09:00 – 17:00
5th Floor – North Wing
Westminster Bridge Road
London SE1 7EH
Telephone – 020 7188 3421

Flow Cytometry/Immunophenotyping Laboratory at Guy's and St Thomas' Clinical Advisory Service
Monday – Friday 09:00 – 17:00
Haematology:
Natalia.Curto-Garcia@gstt.nhs.uk
Jennifer.OSullivan@gstt.nhs.uk
Hugues.DeLavallade@gstt.nhs.uk
Histopathology:
Anna.Green@gstt.nhs.uk
Yurina.Miki@gstt.nhs.uk
Mark.Ong@gstt.nhs.uk
Platelet Glycoprotein:
Aine.McCormick@viapath.co.uk
Oliver.M.Galvez@gstt.nhs.uk

Flow Cytometry/Immunophenotyping Laboratory at Guy's and St Thomas' Technical Advisory Service
Monday – Friday 09:00 – 17:00
Oliver.M.Galvez@gstt.nhs.uk
Yvonne.Daniel@gstt.nhs.uk

For clinical advice or interpretation of results, please contact the laboratory in the first instance.

Print as a PDF

Last updated: 29/09/2022